Balance Sheet

v3.26.3

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 73,023	$ 216,890
Accounts receivable, net	25,712	25,498
Inventory	43,247	40,495
Prepaid expenses and other current assets	12,020	13,368
Total current assets	154,002	296,251
Property and equipment, net	135,671	151,479
Goodwill	129,429	129,429
Intangible assets, net	130,966	151,543
Other assets	49,999	41,875
Total assets	600,067	770,577
Current liabilities:
Accounts payable	6,483	2,910
Accrued expenses and other current liabilities	25,077	36,567
Current portion of long-term debt	1,500	5,440
Total current liabilities	33,060	44,917
Long-term debt, less current portion	145,678	286,331
Finance lease liabilities, less current portion	29,298	30,141
Other long-term liabilities	51,861	36,477
Total liabilities	259,897	397,866
Commitments and contingencies (Note 6)
Stockholders’ equity:
Additional paid-in capital	212,703	199,177
Retained earnings (accumulated deficit)	(19,870)	10,118
Accumulated other comprehensive income	456	524
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc.	195,888	212,379
Non-controlling interest	144,282	160,332
Total stockholders’ equity	340,170	372,711
Total liabilities and stockholders’ equity	600,067	770,577
Class A Common Stock
Stockholders’ equity:
Common stock	1,492	1,453
Class B Common Stock
Stockholders’ equity:
Common stock	$ 1,107	$ 1,107

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source